COR vs. CAH, MCK, ALC, IDXX, IQV, HUM, TAK, CNC, HLN, and MRNA
Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Cardinal Health (CAH), McKesson (MCK), Alcon (ALC), IDEXX Laboratories (IDXX), IQVIA (IQV), Humana (HUM), Takeda Pharmaceutical (TAK), Centene (CNC), Haleon (HLN), and Moderna (MRNA). These companies are all part of the "medical" sector.
Cardinal Health (NYSE:CAH) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership, community ranking and analyst recommendations.
In the previous week, Cardinal Health had 11 more articles in the media than Cencora. MarketBeat recorded 13 mentions for Cardinal Health and 2 mentions for Cencora. Cencora's average media sentiment score of 0.61 beat Cardinal Health's score of 0.50 indicating that Cardinal Health is being referred to more favorably in the media.
Cardinal Health presently has a consensus price target of $107.57, indicating a potential upside of 8.57%. Cencora has a consensus price target of $233.90, indicating a potential upside of 5.30%. Given Cencora's higher possible upside, equities research analysts clearly believe Cardinal Health is more favorable than Cencora.
Cardinal Health received 165 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 71.66% of users gave Cardinal Health an outperform vote while only 65.12% of users gave Cencora an outperform vote.
Cardinal Health pays an annual dividend of $2.02 per share and has a dividend yield of 2.0%. Cencora pays an annual dividend of $2.04 per share and has a dividend yield of 0.9%. Cardinal Health pays out 89.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cencora pays out 22.3% of its earnings in the form of a dividend. Cardinal Health has raised its dividend for 27 consecutive years and Cencora has raised its dividend for 14 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Cencora has higher revenue and earnings than Cardinal Health. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.
Cencora has a net margin of 0.67% compared to Cencora's net margin of 0.25%. Cardinal Health's return on equity of 268.67% beat Cencora's return on equity.
Cardinal Health has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500.
87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.2% of Cardinal Health shares are owned by insiders. Comparatively, 15.8% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Cencora beats Cardinal Health on 11 of the 20 factors compared between the two stocks.
Get Cencora News Delivered to You Automatically
Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
